Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 29;28(3):133-141.
doi: 10.31138/mjr.28.3.133. eCollection 2017 Sep.

The effect of non-steroidal anti-inflammatory drugs on matrix metalloproteinases levels in patients with osteoarthritis

Maria Efstathiou  1 , Loukas Settas  1
Affiliations

The effect of non-steroidal anti-inflammatory drugs on matrix metalloproteinases levels in patients with osteoarthritis

Maria Efstathiou et al. Mediterr J Rheumatol. .

Abstract

Objective: The objective of this study is to determine and comparatively evaluate the effects of three different non-steroidal anti-inflammatory drugs on the levels of metalloproteinases MMP-1, MMP-3 and MMP-8, as well as on their tissue inhibitor TIMP-1, in patients suffering from idiopathic osteoarthritis. The effect of these drugs on the articular cartilage and the probable use of MMPs and TIMP-1 as markers of disease and treatment was also investigated.

Methods: Thirty-six patients with OA were selected and allocated to three groups on the basis of their disease location. All patients received anti-inflammatory treatment with special selective COX-2 inhibitors, i.e. celecoxib, meloxicam, aceclofenac. Each drug was given to every patient for three months following a randomized order of administration. Serum levels of MMP-1, MMP-3, MMP-8 and TIMP-1, and ratios MMP-1/TIMP-1, MMP-3/TIMP-1, MMP-8/TIMP-1 were measured before and after treatment.

Results: The use of aceclofenac resulted in no significant variation in either MMPs concentration and MMPs/TIMP-1 ratio. This outcome concerns the three groups and the 36 patients that form them. After all patients had received all three NSAIDs, MMPs and TIMP-1, these parameters were compared to their initial and final median values. A significant reduction in MMP-3 was found so in all OA patients as in the group of knee OA patients.

Conclusions: 1. Of the MMPs studied, MMP-3 levels were found to be significantly reduced after NSAIDs treatment. Therefore, serum MMP-3 levels in OA patients could be proven to be a useful evaluating marker of treatment on the cartilage level. 2. No significant differences were observed among NSAIDs administered with regards to their effect on MMPs and TIMP-1 concentration.

Keywords: NSAIDs; metalloproteinases; osteoarthritis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Effect of celecoxib on MMP-3 concentrations in all patients and in hip OA patients
Figure 2.
Figure 2.
Effect of celecoxib on ratios MMP-3/TIMP-1 and MMP-8/TIMP-1
Figure 3.
Figure 3.
Effect of meloxicam on MMP-1 MMP-3 and MMP-8
See this image and copyright information in PMC

References

    1. Feldson D T, Zhang Y. An update on epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheumatol 1998;41:1343–55. - PubMed
    1. Kuttner K, Goldberg V M. Osteoarthritis disorders. American Academy of Orthopaedic Surgeons. Rosemont: 1995, XXI–V.
    1. Martel-Pelletier J, Welsch D J, Pelletier J P. Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 2001;15:805–29. - PubMed
    1. Poole A R, Howell D S, Etiopathogenesis of Osteoarthritis. In: Moskowitz R W, Howell D S, Goldberg V M, Mankin J H. (eds). Osteoarthritis: Diagnosis and Management. 3rd ed. Philadelphia: Saunders, 2001;29–47.
    1. Shlopov B V, Lie W-R, Mainardi C L, Cole A A, Chubinskaya S, Hasty K A. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997;40:2065–74. - PubMed

LinkOut - more resources